Nicola is Vice President at Neuland Laboratories, leading CMS Business Development across Europe. He brings prior leadership experience from Dishman Carbogen Amcis, Aptuit, and GSK, with a strong track record in pharmaceutical sales and strategic partnerships. Nicola holds a PhD and a postdoc in organic chemistry, along with an MBA in international management. He is based in Switzerland, supporting biotech and pharma clients with tailored CDMO solutions.

Presentation Title: On-Time and Within Specs: Neuland's Journey Through Three Clinical New Chemical Entity Projects

Abstract: This presentation will explore how Neuland successfully navigated challenges across three distinct clinical New Chemical Entity (NCE) projects. Spanning from early-phase clinical delivery through validation and into commercial stages, these case studies will highlight Neuland’s fit-for-purpose expertise in delivering both small molecule and peptide programs to the biotech and pharmaceutical industry.

View company profile